| RS143128153 |
CUL7
|
Health Risk |
Conflicting classifications of pathogenicity |
3M syndrome 1, CUL7-related disorder |
| RS1431284689 |
USP9X
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 99 |
| RS143128547 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 2, Transient Neonatal Diabetes |
| RS143129030 |
FAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143129413 |
ZC3H14
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143129484 |
FKRP
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2I, Walker-Warburg congenital muscular dystrophy |
| RS1431303701 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Hematuria |
| RS143131185 |
CNGB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Achromatopsia 3, Severe early-childhood-onset retinal dystrophy |
| RS143131258 |
PDHX
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E3-binding protein deficiency, Pyruvate dehydrogenase E3-binding protein deficiency |
| RS143131470 |
PRMT7
|
Health Risk |
Conflicting classifications of pathogenicity |
Short stature-brachydactyly-obesity-global developmental delay syndrome, PRMT7-related disorder |
| RS143132980 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Noonan syndrome and Noonan-related syndrome |
| RS143133190 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS1431337923 |
SLC18A2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS143133981 |
SRCAP
|
Health Risk |
Likely pathogenic |
Floating-Harbor syndrome, Floating-Harbor syndrome |
| RS143134864 |
NOTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hajdu-Cheney syndrome, NOTCH2-related disorder |
| RS143136329 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1D, Autosomal recessive nonsyndromic hearing loss 12 |
| RS143136523 |
RAC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies, Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies |
| RS143137111 |
RANBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial acute necrotizing encephalopathy, Familial acute necrotizing encephalopathy |
| RS143137713 |
GYG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polyglucosan body myopathy type 2, Glycogen storage disease XV |
| RS1431381776 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperaldosteronism, familial |
| RS143138491 |
KCNV2
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1431386295 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143138715 |
MAPT
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontotemporal dementia, MAPT-related disorder |
| RS143138885 |
CHIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Chitotriosidase deficiency, Chitotriosidase deficiency |
| RS143139258 |
MYL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy 10 |
| RS143139259 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS1431405050 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS1431407722 |
BCKDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS1431407809 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1431410587 |
CTNS
|
Health Risk |
Likely pathogenic |
Nephropathic cystinosis, Nephropathic cystinosis |
| RS143141689 |
ORC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Meier-Gorlin syndrome 1, Meier-Gorlin syndrome |
| RS143141993 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
OTOF-related disorder, OTOF-related disorder |
| RS143142227 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 77, LOXHD1-related disorder |
| RS1431425358 |
ANKRD1
|
Health Risk |
Conflicting classifications of pathogenicity |
ANKRD1-related dilated cardiomyopathy, Cardiovascular phenotype |
| RS143142641 |
ATP6V0A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cutis laxa with osteodystrophy, ALG9 congenital disorder of glycosylation |
| RS1431427428 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 25 |
| RS1431438300 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS143144732 |
DCLRE1C
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Athabaskan severe combined immunodeficiency |
| RS143144795 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS143145248 |
NPHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1431456617 |
RBM20
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1DD |
| RS143145868 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, APC-related disorder |
| RS143146120 |
VPS13D
|
Health Risk |
Conflicting classifications of pathogenicity |
VPS13D-related disorder, Inborn genetic diseases |
| RS143146734 |
ITGB3
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia 2 |
| RS143148642 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS143149360 |
CDT1
|
Health Risk |
Conflicting classifications of pathogenicity |
CDT1-related disorder, Inborn genetic diseases |
| RS143149579 |
CDC73
|
Health Risk |
Conflicting classifications of pathogenicity |
Parathyroid carcinoma, Hereditary cancer-predisposing syndrome |
| RS143149582 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS143149764 |
B9D1
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel syndrome, type 9 |
| RS143150244 |
FBN3
|
Health Risk |
Conflicting classifications of pathogenicity |
FBN3-related disorder, FBN3-related disorder |
| RS143150260 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Dilated cardiomyopathy 1AA |
| RS143150497 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, LRP2-related disorder |
| RS1431507005 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS1431507497 |
NDUFV2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1431512432 |
FBXO7
|
Health Risk |
Pathogenic |
Parkinsonian-pyramidal syndrome, Parkinsonian-pyramidal syndrome |
| RS143151340 |
QRSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143152014 |
DLAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate dehydrogenase E2 deficiency, Pyruvate dehydrogenase E2 deficiency |
| RS143152201 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Hereditary cancer-predisposing syndrome |
| RS143152287 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 10, Meckel syndrome |
| RS1431523432 |
NEFL
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 1F, Charcot-Marie-Tooth disease type 2E |
| RS1431526147 |
TP53RK
|
Health Risk |
Pathogenic |
Galloway-Mowat syndrome 4, Galloway-Mowat syndrome 4 |
| RS143152775 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer, EGFR-related lung cancer |
| RS143152888 |
FANCM
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Spermatogenic failure 28 |
| RS1431530916 |
IFT140
|
Health Risk |
Pathogenic/Likely pathogenic |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS143153487 |
CSTB
|
Health Risk |
Conflicting classifications of pathogenicity |
Unverricht-Lundborg syndrome, Progressive myoclonic epilepsy |
| RS143153871 |
XRCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group U, Hereditary cancer-predisposing syndrome |
| RS143154211 |
FBXL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 13, Mitochondrial DNA depletion syndrome 13 |
| RS143154982 |
DES
|
Health Risk |
Conflicting classifications of pathogenicity |
Desmin-related myofibrillar myopathy, Cardiovascular phenotype |
| RS143155251 |
LARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS143155406 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, EHMT1-related disorder |
| RS1431556127 |
BRAF
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, 6 conditions |
| RS143155918 |
SPTBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 5, Inborn genetic diseases |
| RS143156114 |
WWP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143156315 |
MCCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylcrotonyl-CoA carboxylase 2 deficiency, Inborn genetic diseases |
| RS143156459 |
EIF2B5
|
Health Risk |
Conflicting classifications of pathogenicity |
Vanishing white matter disease, Vanishing white matter disease |
| RS1431566505 |
CDC73
|
Health Risk |
Conflicting classifications of pathogenicity |
Parathyroid carcinoma, Hereditary cancer-predisposing syndrome |
| RS143156660 |
KIF14
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1431572320 |
GALNT12
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS143158055 |
INTU
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1431580668 |
NPHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1431589133 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS143159110 |
ITGA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa with pyloric atresia, Junctional epidermolysis bullosa with pyloric atresia |
| RS143159780 |
XYLT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Desbuquois dysplasia 1, Inborn genetic diseases |
| RS143160246 |
SMARCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS143160357 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1431604157 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS143160499 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS143160789 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 4 |
| RS143160805 |
USH1C
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143161827 |
FAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
FAT2-related disorder, FAT2-related disorder |
| RS143161842 |
ANKRD17
|
Health Risk |
Likely pathogenic |
Chopra-Amiel-Gordon syndrome, Chopra-Amiel-Gordon syndrome |
| RS143162500 |
DNAH9
|
Health Risk |
Conflicting classifications of pathogenicity |
DNAH9-related disorder, Inborn genetic diseases |
| RS143163262 |
FLT4
|
Health Risk |
Conflicting classifications of pathogenicity |
FLT4-related disorder, Inborn genetic diseases |
| RS143163327 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1431633756 |
ATP7B
|
Health Risk |
Pathogenic |
Wilson disease, Wilson disease |
| RS143163385 |
RNF213
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1431637197 |
ZMPSTE24
|
Health Risk |
Pathogenic |
— |
| RS143163969 |
NPHP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome with renal defect, Senior-Loken syndrome 1 |
| RS143164660 |
TRPM6
|
Health Risk |
Conflicting classifications of pathogenicity |
Intestinal hypomagnesemia 1, TRPM6-related disorder |
| RS143165174 |
XIAP
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked lymphoproliferative disease due to XIAP deficiency, Autoinflammatory syndrome |